Viewing nowGlipiride 4 mg Tablet (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 200704615 · Notified 2007.04.20 · Insurance code 649400050
Improvement of glycemic control in type 2 diabetes mellitus
This medicine is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used alone, and in cases where blood sugar control is not sufficient, it can be combined with other hypoglycemic agents such as insulin or metformin to enhance effectiveness. Particularly, when adequate blood sugar control is challenging with sulfonylureas or metformin monotherapy, the combination of this medication with metformin helps in managing blood sugar levels more effectively. This medicine is used to enhance blood sugar control in patients with type 2 diabetes.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering medicines. When switching from another oral glucose-lowering medicine to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in insulin-dependent diabetes patients or in cases of diabetic ketoacidosis or patients in a coma. Additionally, individuals with a history of allergic reactions to this medication or its components, sulfonylureas, or sulfonamides should not be administered this drug. The use of this medication has not been established in patients with severe liver or kidney dysfunction, thus switching to insulin therapy is recommended. Pregnant or potentially pregnant women, as well as nursing mothers, should not take this medication. Patients with severe infections, those undergoing surgery, or those with severe trauma should ideally receive insulin therapy. Gastrointestinal disturbances such as diarrhea or vomiting can lead to the risk of hypoglycemia due to impaired food absorption, so caution is needed. This medication contains lactose and should not be given to patients with lactose intolerance or related genetic diseases. In the first week of treatment, there is a heightened risk of hypoglycemia; therefore, careful monitoring of blood glucose levels is essential. Situations with a higher risk of hypoglycemia include elderly individuals who may have difficulty cooperating, poor nutritional status or those who skip meals, irregular eating patterns, excessive exercise combined with imbalanced food intake, and alcohol consumption. Patients with renal or hepatic impairment, coexisting endocrine disorders, and the elderly are also at increased risk of hypoglycemia, so caution is required. If other medications are taken concurrently, it may also affect blood sugar control, requiring consultation with a physician. The most common side effect of this medication is hypoglycemia, which may manifest as headache, severe hunger, nausea, fatigue, confusion, sleepiness, loss of consciousness, etc. In the event of hypoglycemia, sugary foods should be consumed immediately, and in severe cases, medical assistance should be sought. During initial administration, visual disturbance or gastrointestinal symptoms (nausea, vomiting, abdominal pain, etc.) may occur. Rarely, abnormal liver function, blood disorders, or allergic reactions may arise, so any unusual symptoms should be reported to a physician immediately. This medication should be taken regularly while adhering to dietary and exercise regimens for optimal blood sugar control. Patients and their families should have a clear understanding of the symptoms and risks related to hypoglycemia, and be prepared to respond swiftly in case hypoglycemia occurs. In cases of extreme stress or illness, blood sugar control may become difficult, thus requiring adjustment in treatment strategies in consultation with healthcare providers. There may be interactions with other drugs taken concurrently, so it is vital to inform the doctor or pharmacist of all currently used medications. Especially when taken with drugs metabolized in the liver, blood sugar control may be affected. Pregnant or nursing women should avoid use as it may affect the fetus or newborn, and it is advisable to switch to insulin therapy if necessary. For children under 18 years of age, safety and efficacy have not been established, thus it is preferable not to use this medication. Elderly individuals may experience reduced kidney function, thus careful dosing adjustments and cautious administration are necessary. In cases of overdose, severe hypoglycemia may occur; thus, it is essential to visit a medical institution promptly for appropriate treatment. This medication should be kept out of the reach of children and stored in its original container; transferring it to another container may lead to decreased quality or misuse.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, skin phototoxic reactions, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degrees and 30 degrees Celsius at room temperature to preserve the medication's effectiveness and safety.
Light blue rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.